SkinLite Cream 25gm
Available Dosages
| SKU | 515 |
|---|---|
| Generic For | Skin Lite |
| Strength | 25 gm |
| Manufacturer | Zydus Healthcare, India |
| Active Ingredient | Hydroquinone 2%, Tretinoin 0.025%, Mometasone Furoate 0.1% |
| Pack Size | Qty | Price Per Pill or Unit | Price | Cart | |
|---|---|---|---|---|---|
| 1 Tube/s | US$ 14.38 | US$ 14.38 | |||
|
|||||
| 3 Tube/s | US$ 12.65 | US$ 37.9612%US$ 43.14 | |||
|
|||||
| 6 Tube/s | US$ 12.50 | US$ 75.0013%US$ 86.28 | |||
|
|||||
SkinLite Cream 2(Hydroquinone 2%) – Affordable Skin Lite Alternative
SkinLite cream contains Tretinoin, Hydroquinone and Mometasone furoate as the main active ingredients. It is a triple combination skin lightening cream used to treat hyperpigmentation of the skin using three of the best and effective skin care ingredients available. Tretinoin is a first generation topical retinoid, which regulates the cell growth and regenerates the outer layer of the skin. The second active ingredient Hydroquinone reduces the color of skin, whereas the third compound Mometasone furoate acts by suppressing inflammation and the immune response associated with inflammation.
What is SkinLite Cream used for?
SkinLite cream is a medication that can be used for pruritis signs of corticosteroid-responsive dermatoses including itching, redness, and swelling. The medicine is a great combination that lightens and brightens your skin complexion. It also has anti-inflammatory properties that help in treating inflammatory skin conditions, such as eczema or dermatitis.
How does SkinLite cream work?
SkinLite cream contains three active ingredients Hydroquinone, Tretinoin, and Mometasone furoate. Hydroquinone is an agent widely used in cosmetics for its ability to lighten the skin. By affecting the synthesis of the melanin (the pigment that gives human skin, eyes, and skin their color), it can gradually bleach the skin, there by treating unwanted dark spots.
Tretinoin, being a metabolite of retinol, is both structurally and pharmacologically related to vitamin A, which regulates the cell growth and regenerates the outer layer of the skin. It makes the surface layer of the skin thinner and pores less likely to become blocked, reducing the occurrence of blackheads, whiteheads, and pimples.
Mometasone furoate is a glucocorticoid that relieves itching and inflammation of eczema, dermatitis, rashes, and other skin allergies.
What medications interact with SkinLite Cream?
Concomitant topical medication, abrasive soaps, and cleansers, cosmetics that have a strong drying effect and products with high concentration of astringents, alcohol, spices or lime should be used with caution because of the possible drug interaction with Skin Lite. Particular caution should be taken while using preparations containing keratolytic agents such as benzoyl peroxide, salicylic acid, or sulfur with this combination drug.
When should SkinLite Cream not be used?
- Skin Lite should not be used in patients with hypersensitivity to any of the ingredients present in this formulation.
- Do not use the drug on the cuts, sunburned skin, or abrasions.
- While using Skin Lite, your skin may become sensitive to sunlight and UV radiations. Therefore, you must avoid unnecessary exposure to sunlight and artificial UV rays (tanning beds or sunlamps). If you do venture out in the sun, use a good sunscreen and wear protective clothing.
- Avoid using this cream if you are breastfeeding unless your physician has told you otherwise. If your physician has recommended this cream while you are breastfeeding, you must not apply it to your chest; this is to avoid exposure of your baby to this medicine.
What are the side effects of SkinLite 25 gm?
Tell your physician as soon as possible if you experience any of the following:
- Itching
- Irritation
- Redness
- Peeling off
- Scaling of the skin
- Stinging of the skin
- Rashes
- Dryness and breaking of the skin if applied around your nose or eyes
- Burning sensation at the site of application
- Blister formation or crusting of the skin
This is not a complete list of all side effects that may occur. If you have any questions about side effects, contact your physician.
How should SkinLite cream be used?
- Take sufficient amount of Skin Lite cream in your hands and apply a thin film over the affected area. Use it once or twice a day. Wash your hands properly after using the medicine.
- Don't let this topical medication come in contact with the delicate parts of your face like eyes, nose, or lips. Wash them thoroughly with water if they are exposed to the medication accidently.
- After using the medicine, a temporary feeling of warmth or slight stinging may occur. In this case, it is necessary to reduce the frequency of the application or to discontinue the treatment. The frequency of application may be increased, or treatment may be resumed when the patient becomes able to tolerate the treatment. If you have any query related to the usage of the drug, please ask your physician.
How long should you use SkinLite cream 25g?
Use SkinLite as long as it is recommended to you. Do not stop in between during the treatment as it may take four to six weeks to see the effects of this medication. If your condition still does not improve after this time, call your physician.
Missed dose of SkinLite 25 gm
Always remember to use the medicine on time. If you miss a dose, then use it as soon as you remember.
How should Skin Lite 25 gm be stored?
Keep the medicine away from heat and flame. Keep the tube tightly closed. Store it at room temperature. Ensure that your children and pets don't have access to the medication.
What is SkinLite Cream 25gm used for?
SkinLite Cream 25gm contains hydroquinone 2% — a depigmenting agent for hyperpigmentation conditions. Indications: melasma (chloasma — hormonal pigmentation affecting the face, particularly in women during pregnancy or on oral contraceptives); post-inflammatory hyperpigmentation (PIH — dark spots following acne, eczema, or skin injury); solar lentigines (age spots/liver spots from UV exposure); and other forms of localised skin hyperpigmentation. Hydroquinone inhibits tyrosinase — the rate-limiting enzyme in melanin synthesis — reducing melanin production in overactive melanocytes. It does not bleach existing melanin but prevents new melanin formation, allowing skin cell turnover to gradually remove pigmented cells. OTC concentration (2%) is FDA-permitted for skin lightening in the USA; 4% requires prescription.
How should SkinLite Cream 2% be applied for melasma?
Apply SkinLite Cream 2% to the hyperpigmented areas only — not to surrounding normal skin (hydroquinone lightens all treated skin, not just pigmented areas). Use twice daily (morning and evening). Morning application: apply to clean dry skin, allow to absorb, then apply SPF 30–50+ sunscreen (mandatory — sun exposure reverses hydroquinone's effect). Evening application: apply after cleansing and drying. Rub in gently. Avoid eyes, nostrils, and oral mucosa. Wash hands immediately after use. Results begin at 4–8 weeks; significant improvement at 8–12 weeks of consistent use. Use for maximum 3–6 months per course — do not use continuously long-term. If no improvement at 12 weeks, reassess (consider 4% hydroquinone or combination therapy).
What are the risks of long-term hydroquinone use?
Long-term continuous hydroquinone use (particularly >6 months) carries significant risks: ochronosis (exogenous ochronosis) — paradoxical permanent blue-grey or blue-black darkening of treated skin, most common with prolonged high-concentration use in darker skin tones (Fitzpatrick Types IV–VI); it is irreversible and very difficult to treat. This is the most serious complication of hydroquinone use. Other long-term risks: contact dermatitis (allergy to hydroquinone); peripheral neuropathy with systemic absorption (rare); renal damage (very rare, theoretically with excessive topical use). Safe use: limit each hydroquinone course to 3–6 months; take 3–4 month breaks between courses; use the minimum effective concentration; strict daily SPF during and after treatment.
What drug interactions apply to SkinLite Cream 2%?
Topical hydroquinone 2% has low systemic absorption — significant systemic drug interactions are not expected. Local interactions: do not use simultaneously with strong topical oxidising agents (benzoyl peroxide can oxidise and deactivate hydroquinone — apply at different times or use separately). Topical tretinoin: frequently combined with hydroquinone for enhanced PIH treatment — apply tretinoin at night, hydroquinone in the morning (or as a pre-combined triple combination cream with corticosteroid). Topical corticosteroids: low-potency corticosteroids are sometimes combined with hydroquinone to reduce the skin irritation hydroquinone can cause and to enhance depigmentation — do not use high-potency steroids long-term for this purpose. Photosensitising medications: hydroquinone itself increases photosensitivity — strict sunscreen use is mandatory; concurrent systemic photosensitisers (tetracyclines, NSAIDs, thiazides) require enhanced sun protection.
How does SkinLite Cream compare to azelaic acid for hyperpigmentation?
Hydroquinone 2–4% and azelaic acid 15–20% are both effective depigmenting agents. Hydroquinone advantages: faster onset (visible fading at 4–8 weeks vs. 8–12 weeks for azelaic acid); stronger depigmentation at 4% concentration; more clinical evidence for melasma. Azelaic acid advantages: no ochronosis risk (can be used long-term without permanent darkening); safer for long-term maintenance; simultaneous acne treatment; safe in pregnancy; does not bleach normal-pigmented skin in the same way. For PIH from acne: azelaic acid is often preferred — simultaneously treats acne and fades PIH without ochronosis risk. For melasma: hydroquinone is typically more effective for initial treatment (particularly 4% with tretinoin); azelaic acid for long-term maintenance after hydroquinone achieves target lightening. Many dermatologists use hydroquinone short-term cycles alternating with azelaic acid maintenance.
Is SkinLite Cream 2% equivalent to Eldoquin or Lustra cream?
Yes. SkinLite Cream 2% and branded Eldoquin 2% / Lustra 2% hydroquinone creams all contain hydroquinone 2% as the active depigmenting ingredient. SkinLite is the generic/equivalent alternative providing the same OTC-strength skin lightening therapy at significantly lower cost. PremiumRxDrugs.com stocks authentic manufacturer-sourced SkinLite Cream 25gm verified for quality and active ingredient content.
Can I order SkinLite Cream from PremiumRxDrugs for international delivery?
Yes. PremiumRxDrugs.com ships SkinLite Cream 25gm to the USA, UK, Australia, and many other countries. Our genuine manufacturer-verified depigmenting products, competitive pricing, and free worldwide shipping on qualifying orders make us a reliable international source for hydroquinone skin lightening therapy.
What side effects does SkinLite Cream 2% cause?
Common: mild redness, dryness, stinging, or burning at application site (particularly with first use — usually diminishes within 1–2 weeks). Temporary mild darkening of pigmented areas before lightening occurs (initial stimulation of melanocyte activity). Contact dermatitis: itching, persistent redness, and worsening rash — can be irritant (concentration-related) or allergic (immune-mediated) — patch testing helps differentiate. Ochronosis: the most serious side effect — blue-grey permanent darkening with prolonged high-concentration use in darker skin tones (see long-term risk section). Periungual darkening (around fingernails) with prolonged hand exposure — always wash hands after application. Avoid applying to thin-skinned areas (eyelids) — irritation is more pronounced.
Is SkinLite Cream safe in pregnancy for melasma?
Hydroquinone in pregnancy: FDA Category C — systemic absorption from topical application is low (approximately 35% absorption, but plasma levels remain low with limited skin-area use). However, current guidelines generally recommend avoiding hydroquinone in pregnancy out of an abundance of caution — the limited safety data and theoretical systemic absorption from extensive use argue for safer alternatives during pregnancy. For pregnancy-related melasma (chloasma): the safest approach is daily SPF 50+ sunscreen (melasma is sunlight-driven — photoprotection alone can significantly reduce severity); post-delivery treatment with hydroquinone when breastfeeding is complete; azelaic acid cream (Category B — more established pregnancy safety) is an acceptable alternative during pregnancy if treatment is needed. Discuss with your obstetrician and dermatologist.
Why is strict sun protection essential when using SkinLite Cream?
UV exposure directly reverses hydroquinone's depigmenting effect: melanocytes respond to UV radiation by increasing tyrosinase activity and melanin production — exactly the pathway hydroquinone is blocking. Without daily high-SPF sunscreen (SPF 50+ broad-spectrum UVA+UVB), UV exposure re-stimulates melanin production in previously lightened areas, causing rapid re-pigmentation and neutralising hydroquinone's effect. Clinical reality: patients using hydroquinone without sunscreen see little or no improvement because UV continuously drives new pigmentation faster than hydroquinone can suppress it. Sun protection protocol during SkinLite Cream use: SPF 50+ broad-spectrum sunscreen every morning; reapply every 2 hours during prolonged sun exposure; wear broad-brimmed hat and seek shade; avoid peak UV hours (10am–4pm). Continue sunscreen after stopping hydroquinone to prevent PIH recurrence.
When should SkinLite Cream treatment for melasma be stopped or reassessed?
Stop SkinLite Cream 2% and reassess with a dermatologist when: (1) after a maximum of 3–4 months of continuous use — take a treatment break of equal duration before another course; (2) if no improvement is visible after 12 weeks (consider upgrading to hydroquinone 4% under prescription, or switching to alternative treatments — azelaic acid, tretinoin, chemical peels, laser therapy); (3) immediately if ochronosis signs appear — grey-blue discolouration in previously treated normal skin; (4) if contact dermatitis develops (persistent worsening redness and itch); (5) if pregnancy is confirmed — switch to safer alternatives; (6) if the target lightening is achieved — stop and maintain with sunscreen and azelaic acid rather than continuing hydroquinone indefinitely.
Login
Sign Up
Login
Sign Up